Your browser doesn't support javascript.
loading
Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States.
Yadav, Geeta; Yeung, Jensen; Miller-Monthrope, Yvette; Lakhani, Omair; Drudge, Christopher; Craigie, Samantha; Mendell, Ari; Park-Wyllie, Laura.
Afiliación
  • Yadav G; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Yeung J; FACET Dermatology, Toronto, ON, Canada.
  • Miller-Monthrope Y; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
  • Lakhani O; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Drudge C; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
  • Craigie S; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Mendell A; Probity Medical Research, Waterloo, ON, Canada.
  • Park-Wyllie L; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Dermatol Ther (Heidelb) ; 12(11): 2401-2413, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36131193
Skin conditions such as psoriasis are experienced differently by people with skin of color (SoC) compared with white individuals. Although it is known that psoriasis can vary in how it appears between these groups, other factors that affect care for patients with SoC are not well understood. For this review, we focused on challenges associated with accessing healthcare, receiving a diagnosis, and receiving treatment for psoriasis among people with SoC. A search of the academic literature identified several such challenges for people with SoC in Canada and the United States. A major challenge for people with psoriasis and SoC is having access to care that is compatible with their cultural values and practices. The cost of healthcare and cultural views of psoriasis may influence whether individuals with SoC decide to seek care. People with SoC are more likely to be hospitalized for psoriasis, and their access to physicians may differ compared with white individuals. In addition, differences in how psoriasis appears across racial/ethnic groups may hinder diagnosis. Psoriasis treatments that patients with SoC receive may differ from those that white individuals receive, and people with SoC may be less likely to be properly represented in clinical trials evaluating psoriasis therapies. Taken together, the findings of our review indicate that people with psoriasis and SoC face unique challenges in how they receive medical care for their condition. It is essential that clinicians and other stakeholders in the healthcare system recognize these challenges and work to address them.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2022 Tipo del documento: Article